Obviously big pharma is already making millions off a drug that they don't even confirm was given to Sacra, can't prove made a difference in his case (Sacra received transfusions from Dr. Brantly to get his antibodies plus extensive supportive care). And a drug that may not even be effective against this particular strain of Ebola.
"Sacras doctors cautioned Monday against thinking that TKM-Ebola might be a magic bullet against the often-deadly virus.
We need to carefully assess all the treatments being provided to patients with the Ebola virus, said Dr. Angela Hewlett, the associate medical director of the biocontainment unit. We dont know if it was Dr. Sacras own immune system, the supportive therapy we provided, the blood transfusion from Dr. (Kent) Brantly, TKM-Ebola or a combination of all these factors that helped Dr. Sacra recover.
....The company cautioned that the patients may be infected with a strain of Ebola virus which has emerged subsequent to the strain that our product is directed against, and physicians treating these patients may use more than one therapeutic intervention in an effort to achieve the best outcome.